Gilead Sciences

Aktuelle Nachrichten

Schlagzeilen in der Originalsprache der Quelle.

• Insider Selling: Gilead Sciences (NASDAQ:GILD) CEO Sells 15,000 Shares of Stock (öffnet in neuem Tab)

  MarketBeat · 02.10.2026

• Gilead Sciences (GILD) Stock Sinks As Market Gains: What You Should Know (öffnet in neuem Tab)

  Yahoo Finance · 02.10.2026

• 'Funny little arm': Gilead worker alleges leaders mocked disability, stalled career (öffnet in neuem Tab)

  hcamag.com · 02.10.2026

• Zacks cuts Gilead Sciences stock to Hold rating (öffnet in neuem Tab)

  AD HOC NEWS · 02.10.2026

• Gilead Sciences (NASDAQ:GILD) Combines Top Technical Strength With a High-Quality Breakout Setup (öffnet in neuem Tab)

  ChartMill · 02.10.2026

• 
  More Upside Awaits for Gilead Sciences Stock. Stay Invested. (öffnet in neuem Tab)

  02.10.2026

• Confluence Investment Management LLC Cuts Position in Gilead Sciences, Inc. $GILD (öffnet in neuem Tab)

  MarketBeat · 01.10.2026

• Gilead Sciences stock after-hours at EUR 131.85: plus 0.62 percent after the Xetra close (öffnet in neuem Tab)

  AD HOC NEWS · 01.10.2026

• 
  Gilead Sciences, Inc. (GILD) Is a Trending Stock: Facts to Know Before Betting on It (öffnet in neuem Tab)

  01.10.2026

• ETFs Bought $76.5 Million of Gilead Sciences (GILD) on Sept. 29 (öffnet in neuem Tab)

  GuruFocus · 01.10.2026

• Gilead Sciences (NASDAQ:GILD) Stock Rating Cut to "Hold" at Zacks Research (öffnet in neuem Tab)

  MarketBeat · 01.10.2026

• Gilead expands lenacapavir licenses: Gilead Sciences stock has 6.53 percent upside (öffnet in neuem Tab)

  AD HOC NEWS · 01.10.2026

• Gilead Sciences (GILD) Declines More Than Market: Some Information for Investors (öffnet in neuem Tab)

  Yahoo Finance · 30.09.2026

• Gilead Sciences Inc. stock underperforms Wednesday when compared to competitors (öffnet in neuem Tab)

  marketwatch.com · 30.09.2026

• CAR T-Cell Therapy Market Forecasts Growth from $7.24B (2026) to $13.78B by 2031, Profiling Bristol-Myers Squibb, Gilead Sciences, Novartis & J&J (öffnet in neuem Tab)

  30.09.2026

• Gilead Sciences (GILD) Tests Its Multi Platform Story On Questions Around Valuation (öffnet in neuem Tab)

  Simply Wall Street · 30.09.2026

• Gilead Sciences (NDQ:GILD): Fighting HIV/AIDS Is Its Economic Engine (öffnet in neuem Tab)

  Stocks Down Under · 29.09.2026

• Gilead Sciences (NASDAQ:GILD) Stock: Stronger HIV Sales Meet Weaker Reported Earnings (öffnet in neuem Tab)

  kalkine.ca · 29.09.2026

• Former Gilead CIO and CSL Chief Digital & Information Officer Mark Hill Joins Sware Board of Directors (öffnet in neuem Tab)

  biospace.com · 29.09.2026

• Small Molecule Drug Discovery - Global Strategic Business Report Forecasts Growth from $61.5B (2024) to $100B by 2030, Profiling AstraZeneca, Gilead Sciences, Merck & Pfizer (öffnet in neuem Tab)

  29.09.2026

• Can Lenacapavir Power Gilead Sciences (GILD)’s Next Growth Phase? (öffnet in neuem Tab)

  Yahoo Finance · 28.09.2026

• Gilead vs. Intuitive Surgical: Which Healthcare Stock Offers the Better Risk-Adjusted Upside? (öffnet in neuem Tab)

  28.09.2026

• Gilead Sciences stock last trades at USD 152.43 on September 28, 2026 (öffnet in neuem Tab)

  AD HOC NEWS · 28.09.2026

• Gilead vs. Danaher: Which Healthcare Growth Story is More Convincing? (öffnet in neuem Tab)

  28.09.2026

• Gilead vs. Thermo Fisher: Which Life Sciences Stock has the Stronger Growth Outlook? (öffnet in neuem Tab)

  28.09.2026

• Mirum posts phase 3 hepatitis win for ‘commercially differentiated’ challenger to Gilead, Vir (öffnet in neuem Tab)

  Fierce Biotech · 28.09.2026

• Can Gilead Sciences (GILD) Justify Its Price As It Raises 2026 Guidance And Dividend? (öffnet in neuem Tab)

  28.09.2026

• Gilead vs. Medtronic: Which Healthcare Stock Offers the Better Mix of Growth and Income? (öffnet in neuem Tab)

  27.09.2026

• Gilead vs. Abbott: Which Dividend Healthcare Stock Offers the Better Risk-Reward? (öffnet in neuem Tab)

  27.09.2026

• Gilead or Johnson & Johnson: Is Faster Growth Better than Greater Diversification? (öffnet in neuem Tab)

  27.09.2026